Home›Stock Screener›Ajooni Biotech›Financial Statements

Ajooni Biotech Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Ajooni Biotech (AJOONI) reported revenue ₹182 Cr, net profit ₹4 Cr and EPS ₹0.25, with a net profit margin of 2.2% and ROE of 4.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Ajooni Biotech shareholding analysis to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.20% 2026 data
EBITDA Margin 3.30% 2026 data
Operating Margin 3.00% 2026 data
Return on Assets 3.33% 2026 data
Return on Equity 4.40% 2026 data

Balance Sheet Ratios

Current Ratio 37.50 2026 data
Equity Ratio 75.83% 2026 data
Asset Turnover 1.52 2026 data

AJOONI Revenue, Net Profit & EBITDA — Year-on-Year Growth

AJOONI YoY (March 2025 vs March 2026) — revenue +55.6%, net profit +33.3%, expenses +58.6%. Also explore AJOONI share price history to track price trends across different timeframes.

Revenue Growth
+55.6%
Year-over-Year
Net Profit Growth
+33.3%
Year-over-Year
Expense Growth
+58.6%
Year-over-Year
Assets Growth
+26.3%
Year-over-Year
Equity Growth
+3.4%
Year-over-Year
Operating Cash Flow Growth
-178.3%
Year-over-Year
Investing Cash Flow Growth
-312.5%
Year-over-Year
Financing Cash Flow Growth
+725.0%
Year-over-Year

AJOONI Income Statement — Revenue, EBITDA & Net Profit

Ajooni Biotech revenue ₹182 Cr, EBITDA ₹6 Cr, net profit ₹4 Cr, EPS ₹0.25 (2026) — net profit margin 2.2%. For live price, earnings ratios and company overview, see Ajooni Biotech screener.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 182 117 82 75 74 51 40 40 43 29 13 7
Expenses 176 111 78 72 71 49 39 39 42 28 13 7
EBITDA 6 6 4 3 3 2 1 1 1 1 0 0
Operating Profit Margin % 3.00% 3.00% 3.00% 4.00% 4.00% 3.00% 3.00% 2.00% 2.00% 2.00% 2.00% 2.00%
Depreciation 2 1 1 1 1 1 1 0 0 0 0 0
Interest 1 0 1 1 1 1 0 0 0 0 0 0
Profit Before Tax 6 4 3 2 2 1 1 1 1 0 0 0
Tax 2 1 1 1 0 0 0 0 0 0 0 0
Net Profit 4 3 2 1 1 0 0 0 0 0 0 0
Earnings Per Share (₹) 0.25 0.20 0.25 1.94 0.21 0.37 0.41 0.67 0.66 8.34 4.11 3.10

AJOONI Balance Sheet — Assets, Liabilities & Shareholders' Equity

AJOONI total assets ₹120 Cr, total equity ₹91 Cr, total liabilities ₹ Cr (2026) — ROE 4.4%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 120 95 48 59 29 28 23 18 19 13 2 2
Current Assets 75 62 32 35 22 21 18 12 11 6 2 1
Fixed Assets 26 11 10 6 6 5 2 1 1 1 0 0
Capital Work in Progress 0 0 1 0 0 0 0 0 0 0 0 0
Investments 40 4 2 4 1 1 3 0 0 0 0 0
Other Assets 0 80 34 48 22 22 18 17 18 12 2 1
LIABILITIES
Total Liabilities
Current Liabilities 2 2 2 2 3 2 1 4 2 4 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 91 88 43 42 16 16 16 12 11 1 1 0
Share Capital 35 34 18 18 10 10 8 6 6 0 0 0
Reserves & Surplus 57 54 25 24 6 6 8 6 5 1 0 0

AJOONI Cash Flow Statement — Operating, Investing & Financing

Ajooni Biotech operating cash flow ₹-18 Cr, investing ₹-17 Cr, financing ₹25 Cr, net cash flow ₹-10 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -18 23 -6 4 1 -4 -5 -3 -3 -1 0
Investing Activities -17 8 -16 -2 -3 1 1 -1 -2 0 0
Financing Activities 25 -4 22 -2 2 3 -1 8 5 1 0
Net Cash Flow -10 27 0 0 0 -1 -5 5 0 0 0